Charles F Wagner Jr sold $1.6M of Vertex Pharmaceuticals Incorporated (VRTX)

Executed Nov 11 2024, disclosed Nov 13 2024, 2 days later.

Value, as filed

$1.6M

3,000 sh × $518.27

Executed

Nov 11 2024

the trade date, as filed

Disclosed

Nov 13 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CJ Charles F Wagner Jr EVP, CO & FO profile →

Charles F Wagner Jr (EVP, CO & FO) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $6.4M of VRTX (14,000 sh across 2 lots, as filed), executed Dec 3 2025.

The name

VRTX Vertex Pharmaceuticals Incorporated VRTX · Healthcare · 90 filings in 24 months ticker →

Healthcare · Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Charles F Wagner Jr in VRTX

VRTXSALE Vertex Pharmaceuticals Incorporated $4.4M
9,532 sh × $461.00
Exec Jan 6
Filed Jan 8 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $6.4M
14,000 sh across 2 lots
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated $1.6M
3,298 sh × $500.00
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET